10x Genomics (TXG) Intangibles (2020 - 2026)

10x Genomics has disclosed Intangibles across 7 years of filings, most recently posting $59.9 million for Q1 2026.

• Intangibles for Q1 2026 came in at $59.9 million, up 294.35% year-over-year; the trailing twelve-month figure through Mar 2026 was $59.9 million (up 294.35% YoY), and the FY2025 annual result was $62.3 million, up 297.73% from the prior year.
• Intangibles came in at $59.9 million for Q1 2026 at 10x Genomics, down from $62.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $64.8 million in Q3 2025 to a low of $200000.0 in Q4 2023.
• The 5-year median for Intangibles is $22.3 million (2023), against an average of $26.1 million.
• Across the five-year window, Intangibles tumbled 99.13% in 2023 and surged 7735.5% in 2024, its largest moves.
• 10x Genomics' Intangibles stood at $22.9 million in 2022, then sank by 99.13% to $200000.0 in 2023, then soared by 7735.5% to $15.7 million in 2024, then jumped by 297.73% to $62.3 million in 2025, then retreated by 3.88% to $59.9 million in 2026.
• The last three Intangibles figures came in at $59.9 million (Q1 2026), $62.3 million (Q4 2025), and $64.8 million (Q3 2025), per Business Quant data.